
X-tosis Inc
UnclaimedPharmaceutical Preparation ManufacturingGainesville, FL
Founded
2024
Primary NAICS
325412
CAGE code
0NQ46
Federal awards
—
Overview
X-Tosis is developing innovative drugs that target neurodegeneration and mitochondrial dysfunction. Our lead compounds are designed to inhibit VDAC1, protecting neurons from apoptosis and slowing the progression of Alzheimer
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals